Despite the many basic research discoveries in genetics, relatively few gene-based treatments, drugs, or preventative measures have been developed. One way to bridge this gap may be for industry, academia, and government to develop partnerships that share resources while distributing risk. However, intellectual property protections and other barriers can inhibit collaborative efforts. The Institute of Medicine held a workshop on July 22, 2010, to explore these issues and develop solutions.–Publisher’s description.
Medicine
{PDF} Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Drug Development: Workshop Summary Roundtable on Translating Genomic-Based Research on Health, Institute of Medicine
$9.99


![[PDF] Improving Palliative Care for Cancer National Cancer Policy Board, National Research Council, Institute of Medicine, Kathleen M. Foley, Hellen Gelband](https://digzon.com/wp-content/uploads/2024/04/247a324e47180910fba8cb4666a4c304-d.jpg)
![[PDF] Progress in Preventing Childhood Obesity In collaboration with the Healthcare Georgia Foundation, Committee on Progress in Preventing Childhood Obesity, Food and Nutrition Board, Institute of Medicine, National Academies](https://digzon.com/wp-content/uploads/2024/04/2109c622d0552f85f9a339b3c01081fc-d.jpg)
![[PDF] Direct-to-Consumer Genetic Testing: Summary of a Workshop Committee on Science, Technology, and Law, Forum on Drug Discovery, Roundtable on Translating Genomic-Based Research for Health, National Research Council, Institute of Medicine](https://digzon.com/wp-content/uploads/2024/04/19889e8ad308948e2abb54fac7c12fc7-d.jpg)
![[PDF] Corporate Restructuring and Industrial Research and Development The Academy Industry Program of the National Academy of, National Academy of Engineering, Institute of Medicine](https://digzon.com/wp-content/uploads/2024/04/d2935cd8c4c6572d459316429d08d607-d.jpg)
Reviews
There are no reviews yet.